» Articles » PMID: 6170079

The Pharmacology of the Fluoropyrimidines

Overview
Journal Pharmacol Rev
Specialty Pharmacology
Date 1981 Mar 1
PMID 6170079
Citations 39
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Prevalence of 5-Fluorouracil and Capecitabine Cardiotoxicity: A Systematic Review and Meta-Analysis.

Sapapsap B, Thongnoi P, Pongpun A, Kitcharoenpanya S, Todsarot T, Petchsomrit A World J Oncol. 2024; 15(6):902-921.

PMID: 39697430 PMC: 11650610. DOI: 10.14740/wjon1920.


Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based Study.

Shanmuganathan J, Kragholm K, Tayal B, Polcwiartek C, Ostergaard Poulsen L, El-Galaly T JACC CardioOncol. 2022; 3(5):725-733.

PMID: 34988482 PMC: 8702810. DOI: 10.1016/j.jaccao.2021.11.001.


Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.

Wang W, Cui J, Ma H, Lu W, Huang J Front Oncol. 2021; 11:684961.

PMID: 34123854 PMC: 8194085. DOI: 10.3389/fonc.2021.684961.


Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.

Saif M Onco Targets Ther. 2020; 13:10197-10206.

PMID: 33116601 PMC: 7553662. DOI: 10.2147/OTT.S264156.


High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity.

Kluck G, Durham K, Yoo J, Trigatti B Front Cardiovasc Med. 2020; 7:65.

PMID: 32411725 PMC: 7198830. DOI: 10.3389/fcvm.2020.00065.